David C. Pratt Cancer Center at St. John's Mercy is a clinical research site located in St Louis, Missouri, United States 63141.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
David C. Pratt Cancer Center at St. John's Mercy has participated in 73 clinical trials with 1 currently active.
Therapeutic areas: Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer, Breast Cancer.
Sponsors: Wellstat Therapeutics, SWOG Cancer Research Network, NSABP Foundation Inc.
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
David C. Pratt Cancer Center at St. John's Mercy has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
David C. Pratt Cancer Center at St. John's Mercy has 73 clinical trials on record, with 1 currently active. Their work covers Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer, Breast Cancer.
David C. Pratt Cancer Center at St. John's Mercy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.